FDA
-
-
-
-
-
-
-
Hemostemix Files for Ethics Approval of its Study of Vascular Dementia
-
-
-
-
-
-
-
Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio
-
-
-
-
-
-
-
Hemostemix Announces Submission of Orphan Drug Designation Application to the FDA
-
-
-
-
-
-
-
Hemostemix Announces Addition to Its Clinical Trial Management Team
-
-
-
-
330,739 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

